Avatrombopag Maleate: A Comprehensive Guide to its Mechanism, Applications, and Market Insights
Unlock the potential of Avatrombopag Maleate for enhanced platelet production and thrombocytopenia management.
Get a Quote & SampleProduct Core Value
Avatrombopag Maleate
Avatrombopag Maleate (CAS 677007-74-8) is a significant orally active thrombopoietin receptor agonist. Its primary function is to stimulate megakaryopoiesis, thereby increasing platelet production. This makes it a crucial therapeutic agent for managing conditions characterized by low platelet counts, such as thrombocytopenia.
- Understanding the Avatrombopag Maleate mechanism of action reveals its ability to target and activate the thrombopoietin receptor, promoting the development and maturation of megakaryocytes.
- Explore the diverse Avatrombopag Maleate uses, primarily focusing on its efficacy in treating immune thrombocytopenia and thrombocytopenia in patients with chronic liver disease requiring surgical procedures.
- Review the compelling Avatrombopag Maleate clinical trials data, demonstrating significant improvements in platelet counts and reduced bleeding events.
- Discover insights into the Avatrombopag Maleate API price and connect with reliable Avatrombopag Maleate manufacturer options to ensure supply chain continuity.
Key Advantages
Oral Administration Convenience
Experience the ease of oral thrombopoietin receptor agonist therapy, allowing for convenient at-home treatment and reduced need for clinical visits.
Effective Platelet Count Enhancement
This solution offers significant platelet count enhancement, proving beneficial for patients with conditions like immune thrombocytopenia, where managing platelet levels is critical.
Support for Medical Procedures
Avatrombopag Maleate is a valuable tool in providing support for medical procedures and surgical interventions in patients with chronic liver disease and associated thrombocytopenia.
Key Applications
Treatment of Thrombocytopenia
A primary application is the direct treatment of thrombocytopenia, a critical condition affecting blood clotting and overall health.
Platelet Stimulation
The compound effectively engages in platelet stimulation, which is vital for patients with conditions hindering natural platelet production.
Support for Medical Procedures
It serves as crucial support for patients undergoing medical or dental procedures, helping to manage risks associated with low platelet counts.
Immune Thrombocytopenia Management
This therapeutic agent offers a new avenue for managing immune thrombocytopenia, a disorder where the immune system attacks platelets.
Related Technical Articles & Resources
Why Choose Us?
Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.
Global Experience
With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.
Advanced Facilities
Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.
Seamless Scalability
We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).